Literature DB >> 21447990

Macular Dysfunction in Oguchi Disease with the Frequent Mutation 1147delA in the SAG Gene.

Takaaki Hayashi1, Satoshi Tsuzuranuki, Kenichi Kozaki, Mitsuyoshi Urashima, Hiroshi Tsuneoka.   

Abstract

AIM/
BACKGROUND: A 1-bp deletion (1147delA) in the SAG (also known as arrestin or S-antigen) gene is the most frequently seen mutation in Japanese patients suffering from Oguchi disease, a recessively inherited stationary night blindness. We investigated macular function in a patient with Oguchi disease with the 1147delA mutation.
METHODS: A 43-year-old Japanese male patient was diagnosed with Oguchi disease. The patient underwent complete ophthalmic examinations, including spectral-domain optical coherence tomography and Humphrey visual field testing. Full-field electroretinograms (ff-ERG) and multifocal ERG (mf-ERG) were recorded. Mutational analysis of the SAG gene was performed.
RESULTS: Corrected visual acuity was good in both eyes. Funduscopy showed retinal pigment epithelium atrophy along the vascular arcade bilaterally. The inner segment-outer segment (ISOS) boundary lines were preserved in the foveal and parafoveal areas, whereas ISOS boundary defects and thinning of the outer nuclear layer (ONL) were seen outside the preserved ISOS boundary. Humphrey testing showed significant paracentral field defects in both eyes. In addition to an absence of rod responses, cone and 30-Hz flicker responses were markedly reduced in ff-ERG. The central (ring 1) and paracentral (ring 2) responses with normal latencies were relatively preserved, but the outer waveforms (rings 3-5) were attenuated and prolonged in mf-ERG. The deletion mutation (1147delA) was identified homozygously.
CONCLUSIONS: The reduced/delayed mf-ERG responses and visual field defects in paracentral macula areas are most likely to be correlated with ISOS boundary defects and thinning of the ONL. Macular dysfunction can occur in Oguchi disease with the 1147delA mutation in the SAG gene.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447990     DOI: 10.1159/000325024

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  6 in total

1.  Oguchi disease masked by retinitis pigmentosa.

Authors:  Hiroko Sonoyama; Kei Shinoda; Chie Ishigami; Yumi Tada; Hidenao Ideta; Ryuichi Ideta; Masayo Takahashi; Yozo Miyake
Journal:  Doc Ophthalmol       Date:  2011-09-16       Impact factor: 2.379

2.  Assessing retinal structure in complete congenital stationary night blindness and Oguchi disease.

Authors:  Pooja Godara; Robert F Cooper; Panagiotis I Sergouniotis; Melissa A Diederichs; Megan R Streb; Mohamed A Genead; J Jason McAnany; Andrew R Webster; Anthony T Moore; Adam M Dubis; Maureen Neitz; Alfredo Dubra; Edwin M Stone; Gerald A Fishman; Dennis P Han; Michel Michaelides; Joseph Carroll
Journal:  Am J Ophthalmol       Date:  2012-09-07       Impact factor: 5.258

3.  A Chinese family with Oguchi's disease due to compound heterozygosity including a novel deletion in the arrestin gene.

Authors:  Lingli Huang; Wen Li; Weilin Tang; Xiaohua Zhu; Pingbo Ou-Yang; Guangxiu Lu
Journal:  Mol Vis       Date:  2012-03-01       Impact factor: 2.367

4.  Clinical Findings in Four Siblings with Genetically Proven Oguchi Disease.

Authors:  Cagri Ilhan; Mehmet Citirik; Mehmet Yasin Teke; Selda Celik Dulger
Journal:  J Curr Ophthalmol       Date:  2020-12-12

5.  A compound heterozygous mutation in the S-Antigen Visual Arrestin SAG gene in a Chinese patient with Oguchi type one: a case report.

Authors:  Zhen Deng; Fangli Fan; Danyan Tang; Yifeng Wu; Yujie Shu; Kunlin Wu
Journal:  BMC Ophthalmol       Date:  2022-03-04       Impact factor: 2.209

6.  Rhythmic Regulation of Photoreceptor and RPE Genes Important for Vision and Genetically Associated With Severe Retinal Diseases.

Authors:  Patrick Vancura; Erika Csicsely; Annalisa Leiser; P Michael Iuvone; Rainer Spessert
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.